FDA.reportPublic FDA data

Nesina 25 MG Oral Tablet

RxCUI
1368012
RxNorm name
Nesina 25 MG Oral Tablet
Display name
Nesina 25 MG Oral Tablet
Full name
Nesina 25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NesinaALOGLIPTINTakeda Pharmaceuticals America, Inc.a3768c7e-aa4c-44d3-bc53-43bb7346c0b02025-02-28Warnings, Adverse reactionsExact identifier
rxcui: 1368012

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a3768c7e-aa4c-44d3-bc53-43bb7346c0b0Nesina 25 MG Oral Tablet [PSN] · alogliptin 25 MG Oral Tablet [Nesina] [SBD] · Nesina 25 MG (as alogliptin benzoate 34 MG) Oral Tablet [SY] · Nesina 25 MG Oral Tablet [SY]422These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 201320250228